Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health

Haider, A., Meergans, U., Traish, A., Saad, F., Doros, G., Lips, P., & Gooren, L. (2014). Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years. International Journal of Endocrinology, 2014(), 921-929-097. https://doi.org/10.1155/2014/496948
周玉、詹淑月、陳儷今、朱建榮（2003）。Osteoporosis in Athletes: Diagnosis and Treatment。文化體育學刊，()，13-26。https://doi.org/10.6634/JPSS-CCU.200301.01.02
Miazgowski, T., Kleerekoper, M., Felsenberg, D., Stepán, J. J., & Szulc, P. (2012). Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration. Journal of Osteoporosis, 2012(), 208-209. https://doi.org/10.1155/2012/907214
Shetty, S., Kapoor, N., Naik, D., Asha, H. S., Prabu, S., Thomas, N., Seshadri, M. S., & Paul, T. V. (2014). Osteoporosis in Healthy South Indian Males and the Influence of Life Style Factors and Vitamin D Status on Bone Mineral Density. Journal of Osteoporosis, (2014), 106-110. https://doi.org/10.1155/2014/723238
Li, C. X., Tang, S. T., & Zhang, Q. (2015). Changes in Bone Mineral Density and Metabolic Parameters after Pulsatile Gonadorelin Treatment in Young Men with Hypogonadotropic Hypogonadism. International Journal of Endocrinology, 2015(), 700-704-075. https://doi.org/10.1155/2015/324524